Malaria is a devastating disease causing approximately 584,000 deaths in 2013,[@R1] but diagnosis still remains a challenge.[@R2] Microscopic examination of thin or thick smears of peripheral blood remains the gold standard for the last 100 years. However, it is well documented in many areas that this method is time consuming and misdiagnosis is common especially in mixed infection and/or when the parasitemia is low.[@R3] Molecular methods such as conventional polymerase chain reaction (PCR) and real-time PCR may represent a better alternative for malaria diagnosis; however, large-scale application of molecular methods for malaria surveillance has not been implemented, largely due to the high cost of the equipment used.

Loop-mediated isothermal amplification (LAMP) is a rapid and cheap molecular method that enables DNA amplification under isothermal conditions. It is capable in the diagnosis of a wide range of microorganisms associated with bacterial, viral, parasitic, and other diseases in the biomedical field.[@R4]--[@R7] Several LAMP methods have also been developed for malaria diagnosis based on *Plasmodium falciparum* histidine-rich protein-2 (*PfHRP2*),[@R8] *18S rRNA*,[@R9] *Plasmodium berghei* sporozoite protein with MACPF related domain (*PbSPECT2*),[@R10] beta tubulin (*β-tubulin*),[@R11] *Plasmodium falciparum* gametocyte specific genes (*Pfs*)16 and *Pf*s25,[@R12] mitochondrial DNA,[@R13] and apical membrane antigen 1 (*AMA-1*).[@R14] However, up to date, none of the LAMP assays were designed to detect and differentiate all five human malaria parasites (*Plasmodium falciparum*, *Plasmodium vivax*, *Plasmodium malariae*, *Plasmodium knowlesi*, and *Plasmodium ovale*). In this study, we report the attainment of higher sensitivity of detection of all five human malaria species through the use of LAMP method developed based on *Plasmodium* small subunit ribosomal RNA (18S rRNA). Results from LAMP were compared with microscopic examination and nested PCR.

Patients, who presented with fever associated with symptoms that doctors on duty considered indicative of a malaria infection (e.g., headache) (*N* = 181), and healthy donors (*N* = 20) blood samples were collected from University Malaya Medical Center (UMMC), Kuala Lumpur, Malaysia, and Sabah State Health Department, Sabah, Malaysia. Microscopic examination and immunochromatographic rapid test were performed. This study was approved by the Medical Ethics Committee of UMMC (reference no. 817.18) and Medical Research Ethics Committee (reference no. NMRR-12-949-11328).

*Plasmodium* malaria species were determined by nested PCR targeted at *18S rRNA* gene.[@R15],[@R16] FIP, BIP, F3, and B3 primers were designed using the Primer-Explorer V3 software (Eiken Chemical Co., Ltd., Tokyo, Japan) based on *18S rRNA* gene sequences of *P. falciparum*, *P. vivax*, *P. malariae*, *P. knowlesi*, and *P. ovale* (GenBank accession nos. AF145334.1, X13926.1, M54897.1, L07560, and AF145337.1, respectively) ([Table 1](#T1){ref-type="table"}). Loop primers (Loop-F and Loop-B) were designed manually. LAMP was carried out according to the manufacturer\'s protocol (Loopamp DNA Amplification Kit with Florescent Detection Reagent; Eiken Chemical Co., Ltd.). The amplification was carried out in a Loopamp real-time turbidimeter (LA-320; Teramecs, Co., Ltd., Tochigi, Japan) with reaction mixture, 4 μL DNA template, and species-specific primers. All experiments were performed in duplicate at least two times. Several endpoint assessments were carried out to confirm the positive reaction. First, the reaction tube was irradiated with the ultraviolet (UV) light; solutions with amplicons showed stronger green fluorescence under UV compared with the solutions without amplicons. Second, hydroxynaphthol blue dye (HNB) was used for the colorimetric detection of LAMP reaction.[@R17] A positive reaction was observed by visualizing the color change from violet to sky blue. In addition, PCR was performed on 4 μL LAMP products using F3 and B3 primers. The PCR products were then confirmed by DNA sequencing.[@R14]

For limit of detection, recombinant plasmids encompassing the target region of the *18S rRNA* gene were constructed for all five *Plasmodium* species. The detection limit of LAMP was determined by serially diluted positive control plasmids. The copy number (10^6^ copies to one copy) was plotted against the threshold time.[@R14] Specificity of each species-specific LAMP was examined using genomic DNAs of the other human *Plasmodium* species and various nonhuman primate *Plasmodium* species (*Plasmodium coatneyi*, *Plasmodium cynomolgi*, *Plasmodium fragile*, *Plasmodium brasilianum*, and *Plasmodium inui*) (American Type Culture Collection \[ATCC\], Manassas, VA).

The clinical specificity and sensitivity of LAMP[@R14] were determined based on the results of 201 whole blood samples. A composite diagnosis for each sample (two of three tests giving the same result) was created and used as a reference for all three test modalities.[@R18]

After microscopic analysis, 132 malaria blood samples (30 *P. falciparum*, 39 *P. vivax*, one *P. malariae*, 57 *P. knowlesi*, one *P. ovale*, and four mixed infections samples) were identified as positive for malaria infections and 49 samples were found to be negative for malaria infections ([Table 2](#T2){ref-type="table"}).

LAMP was found to be optimal with temperature of 65°C for all positive *Plasmodium* species samples were observed. Amplified products were observed as early as 20 minutes, with a maximal sensitivity reached at 35 minutes. LAMP products were observed either with visual inspection, turbidity reading, or by PCR amplification of the LAMP products. An expected band of ∼200 bp was obtained when the specific LAMP product was used as a template for PCR amplification using B3 and F3 primers, whereas no band was observed from samples containing LAMP product of nonspecific *Plasmodium* species or negative control.

The detection limit for LAMP was 10 copies for *P. knowlesi* and *P. ovale* and one copy for *P. vivax*, *P. malariae*, and *P. falciparum*, respectively. Whereas, nested PCR had a detection limit of 100 copies for *P. knowlesi*, *P. ovale* and 10 copies for *P. vivax*, *P. malariae*. The high specificity of each LAMP assay was confirmed by using genomic DNA of other human *Plasmodium* species. Outcomes showed that LAMP was not observed with DNAs of other human *Plasmodium* species, and cross-reactivity does not occurred between species-specific assays. The analytical specificity of LAMP was also examined by testing genomic DNA of nonhuman malaria species, *P. coatneyi*, *P. cynomolgi*, *P. fragile*, *P. brasilianum*, and *P. inui*. No cross-reactivity was observed with DNA from other *Plasmodium* species, except for *P. vivax* LAMP. *Plasmodium* *vivax* LAMP cross-reactivity with *P. cynomolgi* and *P. fragile* predicted as 99% of *18S rRNA* gene nucleotide sequence homology was observed using ClustalW2 (<http://www.ebi.ac.uk/Tools/msa/clustalw2/>) among the three species. To evaluate the clinical sensitivity and specificity of LAMP for detection of all five *Plasmodium* species in human samples, we compared the LAMP method with conventional nested PCR, which target on the *18S rRNA* gene, and microscopic examination. Of the 132 samples tested positive with microscopy (parasitemia ranged from 0.01% to 1.52%), all samples were positive with LAMP and 130 samples were positive with nested PCR ([Table 2](#T2){ref-type="table"}). Specificity and sensitivity of LAMP for all five *Plasmodium* species were 100%, respectively ([Table 3](#T3){ref-type="table"}).

Under microscopy, *P. knowlesi* generally resembles *P. malariae*, and the early stage of *P. knowlesi* trophozoites resembles those of *P. falciparum*. Thus, the laboratory misdiagnosis of *P. knowlesi* is common.[@R19] In this study, two human patients that were initially diagnosed with either *P. knowlesi* or *P. malariae* infection by microscopic examination, presented positive for *P. malariae* and *P. knowlesi*, respectively, by LAMP, whereas nested PCR amplification was unable to detect both of these cases because of very low parasitemia (\< 0.01%). These results also showed that LAMP could be useful as confirmatory test of malaria infection especially in differentiation of *P. malariae* or *P. knowlesi* infection, which could not be easily differentiated under microscope because of morphological similarity.

To our knowledge, this study is the first report of using LAMP for the diagnosis of all the five human malaria species. In this study, *Plasmodium* species DNA was successfully amplified within 35 minutes for all five malaria parasites (*P. falciparum*, *P. knowlesi*, *P. vivax*, *P. malariae*, and *P. ovale*) at 65°C, and the sensitivity of LAMP was 10 times higher compared with nested PCR. All species-specific LAMP assays identified all five human malaria species specifically. In addition, we used HNB dye for the colorimetric detection of the LAMP reaction. The benefit of this LAMP is that the HNB dye allows the test to be interpreted using the naked eye by observing the color change,[@R20] providing a potential rapid point-of-care method for easy detection of malaria with minimal instrumentation. Combine with the high specificity and sensitivity of LAMP to amplify DNA under isothermal conditions within 35 minutes implies that LAMP may possibly be a good substitute for detection of malaria compared with the nested PCR that requires long operation hour and expensive equipment.

However, there are limitations for LAMP. Because of high sensitivity nature of LAMP, cross-contamination can occur easily. This constraint can be easily overcome by careful pipetting, use of clean bench, and LAMP master mix to avoid frequent exposure of the tube to the environment.

In conclusion, LAMP could be a reliable, convenient, and possible substitute for molecular diagnosis of *Plasmodium* infection particularly in high malaria transmission regions. Its low cost and high simplicity make it a potentially useful tool for point-of-care diagnosis. However, this LAMP assay needs an initial screening for pan-*Plasmodium* detection followed by species identification.
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###### 

LAMP primers used in this study

  *Plasmodium* species      Primer                                            Sequence (5′ to 3′)
  ------------------------- ------------------------------------------------- ----------------------------------------------------
  *Plasmodium knowlesi*     FIP                                               GTTGTTGCCTTAAACTTCCTTGTGTTCTTGATTGTAAAGCTTCTTAGAGG
  BIP                       TGATGTCCTTAGATGAACTAGGCTTTGCAAGCAGCTAAAATCGT      
  FLP                       TAGACACACATCGTT                                   
  BLP                       GCACGCGTGCTACACT                                  
  F3                        CCATCTATTTCTTTTTTGCGTATG                          
  B3                        CAGTGGAGGAAAAGTACGAA                              
  *Plasmodium ovale*        FIP                                               ACCTAGTCGGCATAGTTTATGGTTATTAATCAAGAACGAAAGTTAAGGGA
  BIP                       CCTTTCGGGGAAATTTCTTAGATTGTCCCAGAACCCAAAGACTT      
  FLP                       CGGTATCTGATCGTCTTCAC                              
  BLP                       CTTCCTTCAGTACCTTATGAGA                            
  F3                        GCATTTGCCTAAAATACTTCCAT                           
  B3                        TCAATTCTTTTAACTTTCTCGCT                           
  *Plasmodium vivax*        FIP                                               GCCATGTTAGGCCAATACCCTAATGTGTGTATCAATCGAGTTTCT
  BIP                       TAACGGGGAATTAGAGTTCGATTCCTGTAATTTACGCGCCTGCT      
  FLP                       CATCAAAAGCTGATAGGTC                               
  BLP                       GGAGAGGGAGCCTGAGAAATAGC                           
  F3                        AGCGACACGTAATGGATC                                
  B3                        CTTGTCACTACCTCTCTTCT                              
  *Plasmodium falciparum*   FIP                                               AGTAGTCCGTCTCCAGAAAATCTTACTTTGGGGGCATTCGTATT
  BIP                       GCGAAAGCATTTGCCTAATCTATTTAAGATTACGACGGTATCTGATC   
  FLP                       TCACCTCTGACATCTG                                  
  BLP                       GTTAAGGGAGTGAAGACG                                
  F3                        GCTTAGTTACGATTAATAGGAGTA                          
  B3                        AGTCGGCATAGTTTATGGT                               
  *Plasmodium malariae*     FIP                                               GCTTTCGCAGTTGCTTGTCTC-GGGGGCATTTGTATTCAGA
  BIP                       ACGAAAGTTAAGGGAGTGAAGAC-AGTCGGCATAGTTTATGGTT      
  FLP                       CTAAGAATTTCACCTCTGAC                              
  BLP                       GATCAGATACCGTCGTAATC                              
  F3                        AGTTACGATTAATAGGAGTAGCT                           
  B3                        TTACACTATCATCCAACACCT                             

LAMP = loop-mediated isothermal amplification.

###### 

Results of microscopy, nested PCR, and LAMP assay for detection of all *Plasmodium* species from patients and healthy donors samples

  Samples                                  Microscopy   Nested PCR                                                                  LAMP
  ----------------------------- ---------- ------------ --------------------------------------------------------------------------- ---------------------------------------
  *Plasmodium falciparum*       Positive   30           29 + 1[†](#TFN4){ref-type="table-fn"}                                       30 + 1[†](#TFN4){ref-type="table-fn"}
  Negative                      0          1            0                                                                           
  *Plasmodium vivax*            Positive   39           39                                                                          39
  Negative                      0          0            0                                                                           
  *Plasmodium knowlesi*         Positive   57           56 + 2[\*](#TFN3){ref-type="table-fn"} + 1[†](#TFN4){ref-type="table-fn"}   57 + 1[†](#TFN4){ref-type="table-fn"}
  Negative                      0          1            0                                                                           
  *Plasmodium malariae*         Positive   1            1                                                                           1
  Negative                      0          0            0                                                                           
  *Plasmodium ovale*            Positive   1            1                                                                           1
  Negative                      0          0            0                                                                           
  *P. knowlesi*/*P. vivax*      Positive   2            2                                                                           2
  Negative                      0          0            0                                                                           
  *P. knowlesi*/*P. malariae*   Positive   2            0                                                                           2
  Negative                      0          0            0                                                                           
  Microscopy negative           Positive   0            0                                                                           0
  Negative                      69         67           67                                                                          

LAMP = loop-mediated isothermal amplification; PCR = polymerase chain reaction.

Two samples with 0.01% parasitemia (*P. knowlesi*/*P. malariae*) were detected as *P. knowlesi* only by nested PCR.

Microscopy negative samples were detected positive by LAMP and nested PCR. Parasitemia ranged from 0.01% to 1.52%.

###### 

Sensitivity and specificity of LAMP, microscopy, and nested PCR for all five human malaria species detection

  *Plasmodium* species      Method   Specificity (%)   Sensitivity (%)
  ------------------------- -------- ----------------- -----------------
  *Plasmodium falciparum*   LAMP     100               100
  Microscopy                100      96.7              
  Nested PCR                100      96.7              
  *Plasmodium vivax*        LAMP     100               100
  Microscopy                100      100               
  Nested PCR                100      100               
  *Plasmodium knowlesi*     LAMP     100               100
  Microscopy                100      98.2              
  Nested PCR                100      98.2              
  *Plasmodium malariae*     LAMP     100               100
  Microscopy                100      100               
  Nested PCR                100      100               
  *Plasmodium ovale*        LAMP     100               100
  Microscopy                100      100               
  Nested PCR                100      100               
  Mixed infection           LAMP     100               100
  Microscopy                100      100               
  Nested PCR                100      50                

LAMP = loop-mediated isothermal amplification; PCR = polymerase chain reaction.

A composite diagnosis for each sample based on two out of three methods giving the same result was used as reference.
